A recombinant plasmid has been constructed which contains the mature protein coding region of the human serum albumin (HSA) gene. Bacteria containing this plasmid synthesize HSA protein under control of the £ . c o l i trp promoter-operator. The DNA sequence and predicted protein sequence of HSA were determined from the cDNA plasmid and are compared to existing data obtained from direct protein sequencing. The DNA sequence predicts a mature protein of 585 amino acids preceded by a 24 amino acid "prepro" peptide.
INTRODUCTION
Human serum albumin (HSA) is the major protein component i n adult plasma. The protein is produced in the l i v e r and 1s largely responsible for maintaining normal osmolarity in the bloodstream and functions as a carrier for numerous small molecules ( 1 , 2) . The apparent fetal counterpart of HSA is a-fetoprotein (3). The two proteins have similar physicochemical properties and have reciprocal levels of expression in fetal and adult l i v e r ( 4 ) . Rat serum albumin and a-fetoprotein share 34 percent amino acid and 50 percent nucleotide sequence homology (5) . Only partial protein sequence data exists for human a-fetoprotein (6) (7) (8) . The complete protein sequence of HSA has recently been published (9) (10) (11) (12) . The published protein sequences disagree i n about 20 residues as well as in the total number of amino acids in the mature protein [584 amino acids (9); 585 (12) ]. Some evidence suggests that HSA Is i n i t i a l l y synthesized as a precursor molecule (13, 14) . The precursor forms of bovine (15) and rat (16) serum albumin are known to contain 25 and 24 amino acid "prepro" peptide sequences respectively.
Knowledge of the DNA sequence organization of human serum albumin and a-fetoprotein genes w i l l help elucidate evolutionary, regulatory and functional properties of these related proteins. The a v a i l a b i l i t y of p u r i f i e d HSA produced through recombinant DNA technologies more abundantly than i s now possible from blood fractionation may have widespread research and c l i n i c a l impact. In t h i s paper we report the i s o l a t i o n of cDNA clones spanning the entire sequence of the protein coding and 3' untranslated portions of HSA mRNA. These cDNA clones were used to construct a recombinant plasmid which directs the expression i n £ . c o l i of the mature HSA protein from the t r p promoter. We also present the complete nucleotide and predicted ami no acid sequence of HSA.
MATERIALS AND METHODS
Synthesis and Cloning of cDNA. Poly (A)+ RNA was prepared from quickly frozen human l i v e r samples obtained from biopsy or from cadaver donors by either ribonucleoside-vanadyl complex (17) or guanidinium thiocyanate (18) procedures. cDNA reactions were performed essentially as described i n (19) employing as primers either oligo-deoxynucleotides prepared by the phosphotriester method (20) were added and incubation continued at 42° for 45 minutes. Second strand DNA synthesis, SI treatment, size selection on polyacrylamide gels, deoxy (C) t a i l i n g and annealing to pBR322 which was cleaved with PstI and deoxy (6) t a i l e d , were performed as previously described ( 2 1 , 22). The annealed mixture was used to transform IE. c o l i K-12 s t r a i n 294 (23) by a published procedure (24) .
Screening of Recombinant Plasmids with 3 ?P-labeHed Probes.
£ . c o l i transformants were grown on LB-agar plates containing 5 iig/ml t e t r a c y c l i n e , transferred to nitrocellulose f i l t e r paper (Schleicher and
Schuell, BA85) and tested by hybridization using a modification of the 32 i n s i t u colony screening procedure (25) .
P-end labelled (26) oligodeoxynucleotide fragments of from 12 to 16 nucleotides i n length were 32 used as d i r e c t hybridization probes, or P-cDNA probes were synthesized from RNA using oligo(dT) or oligodeoxynucleotide primers (19) . F i l t e r s were hybridized overnight in 5X Denhardt's solution (27) , 5xSSC (lxSSC = 0.15 M NaCl 0.015 M Na C i t r a t e ) , 50 mM Na phosphate pH 6.8, 20 ug/ml salmon sperm DNA at temperatures ranging from 4" to 42° and washed in salt concentrations varying from 1 to O.2xSSC plus 0.1 percent SDS at temperatures ranging from 4° to 42° depending on the length of the 32 P-labelled probe (28) . Dried f i l t e r s were exposed to Kodak XR-2 X-ray film using DuPont Lightning-Plus intensifying screens at -80°.
DNA Preparation and Restriction Enzyme Analysis. Plasmid DNA was prepared in either large scale (29) or small scale ("miniprep"; 30) quantities and cleaved by restriction endonucleases (New England Biolabs, BRL) following manufacturers conditions. Slab gel electrophoresis conditions and electroelution of DNA fragments from gels have been described (31) . Protein Analysis. Two ml cultures of recombinant £ . coli strains were grown in either LB or M9 media plus 5 iig/ml tetracycline to densities of A 550 = 1 # 0 ' P e11eted » washed, repelleted, and suspended in 2 ml of LB or supplemented M9 (M9 + 0.2 percent glucose, 1 ng/ml thiamine, 20 ng/ml standard ami no acids except methionine which was 2 ug/ml; tryptophan was excluded). Each growth media also contained 5 iig/ml tetracycline and 100 M Ci 35 S-methionine (NEN; 1200 Ci/mmol). After 1 hr incubation at 37°, bacteria were pelleted, freeze-thawed and resuspended in 200 ul 50 mM Tris HC1 pH 7.5, 0.12 mM NaEDTA then placed on ice for 10 minutes following subsequent additions of lysozyme to 1 mg/ml, NP40 to 0.2 percent, and NaCl to 0.35 M. The lysate was adjusted to 10 mM MgCl 2 and incubated with 50 Mg/ml DNase I (Worthington) on ice for 30 min. Insoluble material was removed by mild centrifugation. Samples were immunoprecipitated with rabbit anti-HSA (Cappel Labs) and staphylococcal absorbent (Pansorbin; Cal Biochem) as described (34) , and subjected to SDS polyacrylamide gel electrophoresis (35) .
RESULTS AND DISCUSSION
cDNA Cloning. I n i t i a l cDNA clones were obtained by priming human liver mRNA with oligo (dT). They were screened by colony hybridization with both total liver cDNA (to identify clones containing abundant RNA species) and 32 with two P-labelled cDNA preparations obtained by priming liver mRNA with two sets of four 11-base oUgodeoxynucleotides synthesized to represent the possible coding variations for amino acids 546-549 and 294-297 of HSA. Positive colonies never contained more than about the 3' half of the protein coding region of the expected HSA mRNA sequence. (The longest of these recombinants was designated B-44.) Since existing procedures were unable to directly copy an mRNA of the expected size (-2000 bp), synthetic oUgodeoxynucleotides were prepared to correspond to the antimessage strand at regions near the 5' extreme of B-44. From the nucleotide sequence of B-44, we constructed a 12 base oligodeoxynucleotide corresponding to amino acids 369-373. This was used to prime cDNA synthesis of liver mRNA and produce cDNA clones in pBR322 containing the 5 1 portion of the HSA message while overlapping the existing B-44 recombinant. Approximately 400 resulting clones were screened by colony hybridization with a 16 base oligodeoxynucleotide fragment located slightly upstream of the 12 base priming region in the mRNA sequence we had thus far determined. Approximately 40 percent of the colonies hybridized to both probes. Many of those colonies which failed to contain hybridizing plasmids presumably resulted from RNA self-priming or priming with contaminating oligo (dT) during reverse transcription, or lost the 3' region containing the sequence used for screening. "Miniprep" amounts of plasmid DNA from hybridizing colonies were digested with Pstl. Three recombinant plasmids contained sufficiently large inserts to code for the remaining 5' portion of the HSA message. Two of these (F-15 and F-47) contained the extreme 5 1 coding portion of the mature protein message but failed to extend back to a Pstl site necessary for joining with B-44 to reform the complete albumin gene. Recombinant F-61 possessed this Pstl site but lacked the entire 5' end. A three part reconstruction of the entire message sequence was possible employing restriction endonuclease sites in common with the part length clones F-47, F-61 and B-44 (Fig. 1 ).
An additional cDNA clone extending even farther 5' was obtained by similar oligodeoxynucleotide primed cDNA synthesis (from a primer corresponding to amino acid codons no. 175-179). Although not employed in the construction of the mature HSA expression plasmid, this cDNA clone (P-14) allowed determination of the DNA sequence of the "prepro" peptide coding and 5' non-coding regions of HSA mRNA.
The mature HSA mRNA sequence was joined to a vector plasmid for direct expression of the mature protein in £ . coli via the trp promoter-operator. The plasmid pLelF A25 directs the expression of human leukocyte interferon A (IFNa2) (21) . I t was digested with Xbal and the cleavage site " f i l l e d i n " to produce blunt DNA ends with DNA polymerase I Klenow fragment and deoxynucleoside triphosphates. After subsequent digestion with Pstl, a "vector" fragment was gel purified that contained pBR322 sequences and a 300 bp fragment of the £. coli trp promoter, operator, and ribosome binding site of the trp leader peptide terminating in the a r t i f i c i a l l y blunt ended Xbal cleavage site. A 15-base oligodeoxynucleotide was designed to contain the i n i t i a t i o n codon ATG followed by the 12 nucleotides coding for the f i r s t four amino acids of mature HSA as determined by DNA sequence analysis of clone F-47. In a process referred to as "primer repair", the gene containing Pstl fragment of F-47 was denatured, annealed with excess 15-mer and reacted with DNA polymerase I Klenow fragment and deoxynucleoside triphosphates. This reaction extends a new second strand downstream from the annealed oligonucleotide, degrades the single stranded DNA upstream of codon number one and then polymerizes upstream three nucleotides complementary to ATG. In addition, when this product is blunt-end ligated to the prepared vector fragment, i t s i n i t i a l adenosine residue recreates an Xbal restriction s i t e . Following the primer repair reaction, the DNA was digested with Hpall and a 450 bp fragment containing the B) The completed plasmid pHSAl is shown with HSA coding regions derived from cDNA clones shaded as in A). Selected restriction sites and terminal codons number 1 and 585 are indicated as above. The E. coli trp promoter-operator region is shown with an arrow representing tFe direction of transcription. G:C denotes an oligo (dG:dC) t a i l . The leftmost Xbal site and the i n i t i a t i o n codon ATG were added synthetically. The tetracycline (Tc) and ampicillin (Ap) resistance genes in the pBR322 portion of pHSAl are indicated by a heavy l i n e . See the text for further details.
mature albumin gene was gel purified (see Fig. 1 ). This fragment was E. coli cells transformed with albumin expression plasmid pHSAl (lanes 4 ami 5) or control plasmid pLeIFA25 (containing an interferon a gene in the identical expression vehicle; lanes 2, 3 and 7) were grown in 35 S-methionine-supplemented media. Samples in lanes 2, 4 and 7 were induced for expression from the trp promoter in M9 media lacking tryptophan; samples in lanes 3 and 5 were grown in tryptophan-containing LB broth to repress the trp promoter. Each sample lane of the autoradiograph of the SDS-polyacrylamide gel presented here contains labeled protein immunoprecipitated from 0.75 ml of cells at a density of A550 = 1 (see Methods). Lanes 1 and 6 contain radioactive protein standards (BRL) whose molecular weight in kilodaltons is indicated at the l e f t . Bacterially synthesized HSA is seen in lane 4 comigrating with the 68,000 dalton (d) l^C-labeled bovine serum albumin standard. Increased production of serum albumin in the induced versus repressed culture of pHSAl represents higher levels of synthesis of plasmid encoded protein rather than a difference in 35 S-methionine pool specific activities for minimal versus rich media (data not shown). The sharp band at 60,000 d is an apparent a r t i f a c t ; this band is seen in both induced and repressed pHSAl and control transformants, and binds to preimmune (lane 7) as well as anti-HSA IgGs (lanes 2-5). The minor 47,000 d band in lane 4 is apparently plasmid encoded and may represent a prematurely terminated form of bacterially synthesized HSA. the approximately 4 kb fragment was gel purified. This was annealed and ligated to a 390 bp £s_tl, jSgHI partial digestion fragment purified from F-61 and a 1000 bp PstI fragment of B-44. Restriction endonuclease analysis of resulting transformants identified plasmids containing the entire HSA coding sequence properly aligned for direct expression of the mature protein. One such recombinant plasmid was designated pHSAl. When £. coli containing pHSAl is grown in minimal media lacking tryptophan, the cells produce a protein which specifically reacts with HSA antibodies and comigrates with HSA in SDS polyacrylamide electrophoresis (Fig. 2) . No such protein is produced by identical recombinants grown in rich tryptophan containing broth, implying that production in £. coli of the putative HSA protein is under control of the trp promoter-operator as designed. Efforts are now underway to increase the level of protein production in this and other expression systems above the present modest levels. To insure the integrity of the HSA structural gene in the recombinant plasmid, pHSAl was subject to DNA sequence analysis.
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DNA Sequence Analysis
The sequence of the albumin cDNA portion and the adjoining regions of pHSAl were determined by both the chemical degradation method of Maxam and Gilbert (26) and the dideoxy chain termination procedure employing templates derived from single stranded M13 mP7 phage derivatives (32, 33) . The DNA sequence is shown in Fig. 3 along with the predicted amino acid sequence of the HSA protein. The DNA sequence farther 5 1 to the mature HSA coding region was also determined from the cDNA clone P-14 and is included in Fig. 3 .
DNA sequence analysis confirmed that the a r t i f i c a l i n i t i a t i o n codon The DNA sequence of the mature protein coding and 3' untranslated regions of HSA mRNA were determined from the recombinant plasmid pHSAl and the DNA sequence of the prepro peptide coding and 5' untranslated regions were determined from the plasmid P-14 (see t e x t ) . Predicted amino acids are included above the DNA sequence and are numbered from the f i r s t residue of the mature protein. The preceding 24 amino acids comprise the prepro peptide. The five amino acid residues which disagree with the protein sequence of HSA reported by both Dayhoff (9) and Moulon ejt ^K (12) are underlined. The above nucleotide sequence probably does not extend to the true 5' terminus of HSA mRNA. In the albumin direct expression plasmid pHSAl, the mature protein coding region is immediately preceded by the E. coli trp promoter-operator-leader peptide ribosome binding site (36, 37) , an a r t i f i c i a l Xbal s i t e , and an a r t i f i c i a l i n i t i a t i o n codon ATG; the prepro region has been excised. The nucleotides preceding HSA codon no. 1 in pHSAl read 5' -TCACGTAAAAAGGGTATCTAGATG. and the complete mature HSA coding sequence directly follows the £. coli trp promoter-operator as desired. The ATG i n i t i a t o r follows the putative £ . coli ribosome binding sequence (36) of the trp leader peptide (37) by 9 nucleotides.
Translation of the DNA sequence of pHSAl predicts a mature HSA protein of 585 amino acids. Various published protein sequences of HSA disagree at about 20 amino acids. Our sequence differs by eleven residues from Moulon et a h (12) , and by 28 residues from that reported in the Atlas of Protein Sequence and Structure (9) . The Atlas (9) sequence is credited as arising primarily from Behrens et a h (10) with some residues deriving from Moulon eit ah (12) . Most of these differences represent inversions of pairs of adjacent residues or glutamine-glutamic acid disagreements. Only at five of the 585 residues does our sequence differ from the residue reported in both the Atlas (9) and in Moulon et_a]_. (12) , and three of these five differences represent glutamine-glutamic acid interchanges. The five common differences are underlined in Figure 3 . At a l l discrepant positions the nucleotide sequencing has been carefully rechecked and i t is unlikely that DNA sequencing errors are the cause of these reported differences. The possibility of artifacts introduced by cDNA cloning cannot be ruled out. However, other l i k e l y explanations exist for the amino acid sequence differences among various reports. These include changes in ami da t i on (affecting glutamine-glutamic acid discrimination) occurring either in vivo or during protein sequencing (38) . Polymorphism in HSA proteins may also account for some differences; over twenty genetic variants of HSA have been detected by protein electrophoresis (39) but have not yet been analyzed at the amino acid sequence level. I t is also worth noting that our predicted HSA protein sequence is 585 amino acids long, in agreement with reference (12) but not reference (9) . The difference is accounted for by the deletion (in ref. 9) of one phenylalanine (Phe) residue in a Phe-Phe pair at amino acids 156-157.
As sequence information becomes available, i t w i l l be possible to compare albumin genes between different species and with the related a-fetoprotein. When compared to the DNA sequence of a rat serum albumin cDNA clone (16) the mature HSA sequence we report shares 74 percent homology at the nucleotide and 73 percent homology at the amino acid level. (The rat albumin protein is one amino acid shorter than HSA; the carboxy terminal residue of HSA is absent in the rat protein.) All 35 cysteine residues are located in identical positions in both proteins. The predicted "prepro" peptide region of HSA shares 76 percent nucleotide and 75 percent anrino acid homology with that reported from the rat cDNA clone (16) .
Interspecies sequence homology is reduced in the portion of the 3" untranslated region which can be compared (the published rat cDNA clone ends before the 3 1 mRNA terminus). The HSA cDNA contains the hexanucleotide AATAAA 28 nucleotides before the site of poly(A) addition.
This is a common feature of eukaryotic mRNAs f i r s t noted by Proudfoot and Brownlee (40) .
I t has been postulated that albumin and a-fetoprotein genes arose from duplication of a common ancestral gene (5, 41, 42) . The two structural gene sequences are 50 percent homolgous in rats (5) . The complete human a-fetoprotein sequence is not yet available, so this comparison cannot yet be made for the human proteins. Further studies w i l l focus on inter-and intra-species relationships of structure, function, and expression of this related gene pair.
